Dan Williams welcomes news that NICE has raised the cost-effectiveness threshold for ultra-rare disease drugsDr Dan WilliamsOct 81 min readRead the article on how ultra-rare disease drugs are getting a boost from NICE guidelines here>
Dan Williams contributes to a major article for Inside Precision Medicine, in which several US families with a child living with H-ABC discuss their journey to a diagnosis
Comments